The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Prevalence and Predictors of Substance Use Disorders Among HIV Care Enrollees in the United States
Open accessAbstract
Abstract Prior efforts to estimate U.S. prevalence of substance use disorders (SUDs) in HIV care have been undermined by caveats common to single-site trials. The current work reports on a cohort of 10,652 HIV-positive adults linked to care at seven sites, with available patient data including geography, demography, and risk factor indices, and with substance-specific SUDs identified via self-report instruments with validated diagnostic thresholds. Generalized estimating equations also tested patient indices as SUD predictors. Findings were: (1) a 48 % SUD prevalence rate (between-site range of 21–71 %), with 20 % of the sample evidencing polysubstance use disorder; (2) substance-specific SUD rates of 31 % for marijuana, 19 % alcohol, 13 % methamphetamine, 11 % cocaine, and 4 % opiate; and (3) emergence of younger age and male gender as robust SUD predictors. Findings suggest high rates at which SUDs occur among patients at these urban HIV care sites, detail substance-specific SUD rates, and identify at-risk patient subgroups.ResumenLos esfuerzos previos para estimar la prevalencia de los trastornos por uso de sustancias (TUS) de Estados Unidos en la atención del VIH han sido socavados por los problemas comunes de la investigación realizada en un solo sitio. Este documento informa sobre un estudio de una cohorte de 10,652 adultos con VIH que reciben atención en siete sitios, con los datos del paciente disponibles sobre la geografía, la demografía y los índices de factores de riesgo, y con trastornos por uso de sustancias para sustancias específicas identificadas con los instrumentos de autoinforme con umbrales de diagnóstico que han sido validado. Ecuaciones de estimación generalizadas también evaluaron los índices de pacientes como predictores de TUS. Los resultados fueron: 1) una tasa de prevalencia de TUS de 47 % (entre-ubicación gama de 21 a 71 %), con 20 % de la muestra que demuestra un trastorno que implica múltiples sustancias; 2) las tasas SUD por sustancia específica de 31 % para la marihuana, 19 % para el alcohol, 13 % de la metanfetamina, 11 % de la cocaína, y 4 % de los opiáceos; y 3) el surgimiento de menor edad y el sexo masculino como predictores robustos de los trastornos por uso de sustancias. Los resultados sugieren que los pacientes en las clínicas urbanas VIH tienen altas tasas de TUS, describen las tasas de sustancias específicas, e identifican subgrupos de pacientes en situación de riesgo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grant, B. F., Goldstein, R. B., Saha, T. D., Chou, S. P., Jung, J., Zhang, H., Pickering, R. P., Ruan, W. J., Smith, S. M., Huang, B., et al. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.0584 · Cited by 2,556
Bing, E. G., Burnam, M. A., Longshore, D., Fleishman, J. A., Sherbourne, C. D., London, A. S., Turner, B. J., Eggan, F., Beckman, R., Vitiello, B., et al. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.8.721 · Cited by 1,255
Validation of the alcohol smoking and substance involvement screening test (ASSIST)
Humeniuk, R., Ali, R., Babor, T. F., Farrell, M., Formigoni, M. L., Jittiwutikarn, J., De Lacerda, R. B., Ling, W., Marsden, J., Monteiro, M., et al. (2008) · Addiction · doi:10.1111/j.1360-0443.2007.02114.x · Cited by 1,144
Grant, B. F., Saha, T. D., Ruan, W. J., Goldstein, R. B., Chou, S. P., Jung, J., Zhang, H., Smith, S. M., Pickering, R. P., Huang, B., et al. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.2132 · Cited by 877
Hasin, D. S., Kerridge, B. T., Saha, T. D., Huang, B., Pickering, R., Smith, S. M., Jung, J., Zhang, H., & Grant, B. F. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15070907 · Cited by 579
Gaynes, B. N., Pence, B. W., Eron, J. J., & Miller, W. C. (2008) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31816aa0cc · Cited by 143
Self-citationRosenberg, S. D., Drake, R. E., Brunette, M. F., Wolford, G. L., & Marsh, B. J. (2005) · AIDS · doi:10.1097/01.aids.0000192067.94033.aa · Cited by 87
Inter-observer reliability of DSM-5 substance use disorders
Denis, C. M., Gelernter, J., Hart, A. B., & Kranzler, H. R. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.05.019 · Cited by 36 · cited 1×
“Increased care access among persons with SUD due to the Affordable Care Act [5, 6] and strong interrater reliability for the singular DSM-V conceptualization of SUD [7] are recent developments suggesting this as an opportune time for reporting SUD prevalence estimates among HIV care enrollees.”
Background
Cited by
Mental health and HIV/AIDS: the need for an integrated response
Remien, R. H., Stirratt, M. J., Nguyen, N., Robbins, R. N., Pala, A. N., & Mellins, C. A. (2019) · AIDS · doi:10.1097/qad.0000000000002227 · Cited by 727
Dopamine, Immunity, and Disease
Channer, B., Matt, S. M., Nickoloff-Bybel, E. A., Pappa, V., Agarwal, Y., Wickman, J., & Gaskill, P. J. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000618 · Cited by 308
Pergam, S. A., Woodfield, M. C., Lee, C. M., Cheng, G., Baker, K. K., Marquis, S. R., & Fann, J. R. (2017) · Cancer · doi:10.1002/cncr.30879 · Cited by 267
Kahler, C. W., Pantalone, D. W., Mastroleo, N. R., Liu, T., Bove, G., Ramratnam, B., Monti, P. M., & Mayer, K. H. (2018) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000322 · Cited by 88
“The many deleterious effects of heavy drinking on HIV care outcomes underscore the need to develop and evaluate interventions to reduce heavy drinking in PLWH. Men, and in particular men who have sex with men (MSM), have the highest rates of heavy drinking and alcohol use disorders among PLWH (Crane et al., 2017; Hart…”
InfluentialSelf-citationLi, M. J., Su, E., Garland, W. H., Oksuzyan, S., Lee, S.-J., Kao, U. H., Weiss, R. E., & Shoptaw, S. J. (2020) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002351 · Cited by 19
Metadata
- Authors
- Hartzler, B., Dombrowski, J. C., Crane, H. M., Eron, J. J., Geng, E. H., Christopher Mathews, W., Mayer, K. H., Moore, R. D., Mugavero, M. J., Napravnik, S., Rodriguez, B., & Donovan, D. M.
- Venue
- AIDS and Behavior
- Published
- 2016-10-13
- Volume
- 21
- Issue
- 4
- Pages
- 1138-1148
- ISSN
- 1090-7165 (ISSN-L)
- 1573-3254
- OpenAlex
- W2530341614
- Cited by
- 219
- References
- 8
- FWCI
- 8.18
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevalence and Predictors of Substance Use Disorders Among HIV Care Enrollees in the United States. https://app.cochat.ai/papers/10.1007/s10461-016-1584-6
- The paper
- Hartzler, B., Dombrowski, J. C., Crane, H. M., Eron, J. J., Geng, E. H., Christopher Mathews, W., Mayer, K. H., Moore, R. D., Mugavero, M. J., Napravnik, S., Rodriguez, B., & Donovan, D. M. (2017). Prevalence and Predictors of Substance Use Disorders Among HIV Care Enrollees in the United States. AIDS and Behavior. https://doi.org/10.1007/s10461-016-1584-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.